Pages that link to "Item:Q3530110"
From MaRDI portal
The following pages link to Bayesian Optimal Design for Phase II Screening Trials (Q3530110):
Displaying 14 items.
- Optimal design in geostatistics under preferential sampling (Q273629) (← links)
- Optimal Bayesian two-phase designs (Q1378792) (← links)
- Bayesian \(D\)-optimal screening experiments with partial replication (Q1658376) (← links)
- Optimal screening designs with flexible cost and constraint structures (Q1779802) (← links)
- Approximating the operating characteristics of Bayesian uncertainty directed trial designs (Q2156810) (← links)
- Bayesian design for clinical trials with a constraint on the total available dose (Q2736795) (← links)
- A Bayesian Decision Approach for Sample Size Determination in Phase II Trials (Q3078735) (← links)
- Bayesian designs and the control of frequentist characteristics: A practical solution (Q3465748) (← links)
- Adaptive Design Optimization: A Mutual Information-Based Approach to Model Discrimination in Cognitive Science (Q3556782) (← links)
- A Bayesian model for the optimal ordering of a collection of screens (Q3837331) (← links)
- Decision‐theoretic designs for a series of trials with correlated treatment effects using the Sarmanov multivariate beta‐binomial distribution (Q4634681) (← links)
- A class of Bayes-optimal two-stage screens (Q5690158) (← links)
- Estimating optimal dynamic treatment strategies under resource constraints using dynamic marginal structural models (Q6628000) (← links)
- The performance of fixed-horizon, look-ahead procedures compared to backward induction in Bayesian adaptive-randomization decision-theoretic clinical trial design (Q6637190) (← links)
